- Citations, last 5 years
- 37
- Works, last 5 years
- 1
- h-index
- 9
- Scientists listed
- 0
- Grants since 2016
- 1
Grants received
2016–2018 · commercial · H2020 - SME-2
A small molecule AMP activated protein kinase (AMPK) activator, denoted O304, as a novel innovative drug for the treatment of type 2 diabetes
Betagenon (Sweden) · funded by European Commission